BCBS North Carolina Medical Policy Updates – May 2019

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

May 2019 Medical Policy Updates:

• Ablation Procedures for Peripheral Neuromas and Peripheral Nerves
• Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms
• Allogeneic Hematopoietic Transplant for Genetic Diseases and Acquired Anemia
• Alpha 1-Antitrypsin Inhibitor Therapy
• Antiemetic Injection Therapy
• Aqueous Shunts and Devices for Glaucoma
• Balloon Dilation of the Eustachian Tube
• Bioengineered Skin and Tissue
• Brentuximab Vedotin (Adcetris )
• Bronchial Thermoplasty
• Cabazitaxel (Jevtana)
• Carfilzomib (Kyprolis)
• Cochlear Implant
• Continuous Passive Motion in the Home Setting
• Convection-Enhanced Delivery of Therapeutic Agents to the Brain
• Cord Blood as a Source of Stem Cells
• Daratumumab (Darzalex)
• Diagnosis and Treatment of Sacroiliac Joint Pain
• Dynamic Posturography
• Eculizumab (Soliris®)
• Electromagnetic Navigation Bronchoscopy
• Elotuzumab (Empliciti)
• Endobronchial Valves
• Epidural Steroid Injections for Back Pain
• Eribulin Mesylate (Halaven)
• Erythropoiesis-Stimulating Agents (ESAs)
• Facet Joint Denervation
• Genetic Testing for Dilated Cardiomyopathy
• Genetic Testing for Duchenne and Becker Muscular Dystrophy
• Genetic Testing for Epilepsy
• Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins during Breast-Conserving Surgery
• Hematopoietic Stem-Cell Transplantation for Acute Lymphoblastic Leukemia
• Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia
• Hemodialysis Treatment for ESRD
• Hormone Pellet Implantation for Treatment of Menopause Related Symptoms
• Hyperthermic Intraperitoneal Chemotherapy
• Immunoglobulin Therapy
• Implantable Bone Conduction Hearing Aids
• Infliximab, Infliximab-dyyb, Infliximab-abda
• Intracellular Micronutrient Analysis
• Intradialytic Parenteral Nutrition
• Intravenous Anesthetics for the Treatment of Chronic Pain
• Intravitreal Implant
• Ipilimumab (Yervoy)
• Laboratory Tests for Heart Transplant Rejection
• Letermovir (Prevymis™)
• Lipid Apheresis
• Lung and Lobar Lung Transplantation
• Lung Volume Reduction Therapy
• Lysis of Epidural Adhesions
• Maternal and Fetal Diagnostics
• Melphalan Hydrochloride (Evomela) for Intravenous Use
• Microprocessor-Controlled Prostheses for the Lower Limb
• Monoclonal Antibodies for Non-Hodgkin Lymphoma and Acute Myeloid Leukemia In the Non-Hematopoietic Stem Cell Transplant Setting
• Myoelectric Prosthetic Components for the Upper Limb
• Neural Therapy
• Oscillatory Devices for the Treatment of Respiratory Conditions
• Ovarian and Internal Iliac Vein Embolization
• Paclitaxel (Abraxane)®
• Pemetrexed (Alimta)
• Pertuzumab for Treatment of Malignancies
• Powered Exoskeleton for Ambulation in Patients with Lower Limb Disabilities
• Progesterone Therapy in High Risk Pregnancies
• Prolotherapy
• Pulmonary Hypertension, Drug Management
• Radiofrequency Ablation of the Renal Nerves as a Treatment of Hypertension
• Radiosurgery, Stereotactic Approach
• Renal (Kidney) Transplantation
• Semi-Implantable and Fully Implantable Middle Ear Hearing Aid
• Siltuximab (Sylvant)
• Surgery for Groin Pain in Athletes
• Surgery for Obstructive Sleep Apnea and Upper Airway Resistance Syndrome
• Synthetic Cartilage Implants for Joint Pain
• TENS (Transcutaneous Electrical Nerve Stimulator)
• Tinnitus Treatment
• Transtympanic Micropressure Applications as a Treatment of Meniere’s Disease
• Trastuzumab
• Vectra® DA Blood Test for Rheumatoid Arthritis
• White Blood Cell Growth Factors

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.